Sanofi

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines, vaccines franchises, support, and corporate functions 1973 and is headquartered in Paris, France. 

CEO
Belén Garijo López
CEOBelén Garijo López
Employees
76,493
Employees76,493
Headquarters
Paris, Ile-de-France
HeadquartersParis, Ile-de-France
Founded
1973
Founded1973
Employees
76,493
Employees76,493

SNY Key Statistics

Market cap
114.86B
Market cap114.86B
Price-Earnings ratio
24.06
Price-Earnings ratio24.06
Dividend yield
3.76%
Dividend yield3.76%
Average volume
5.69M
Average volume5.69M
High today
$47.16
High today$47.16
Low today
$45.58
Low today$45.58
Open price
$45.65
Open price$45.65
Volume
3.89M
Volume3.89M
52 Week high
$52.68
52 Week high$52.68
52 Week low
$39.07
52 Week low$39.07

SNY News

TipRanks 6h
Sanofi Advances Late-Stage Study of Belumosudil for Chronic Graft-versus-Host Disease

Sanofi SA (SNY) announced an update on their ongoing clinical study. Study Overview: Sanofi’s official study title is “A Parallel Group, Phase 3, Randomized, O...

Zacks 8h
NVAX Stock Falls 8% Despite Q3 Earnings & Sales Beat, Costs Decline

Novavax (NVAX Quick QuoteNVAX - Free Report) recorded a loss of 19 cents per share in the third quarter of 2026, narrower than the Zacks Consensus Estimat...

NVAX Stock Falls 8% Despite Q3 Earnings & Sales Beat, Costs Decline
Investor's Business Daily 2d
Nurix, Sanofi Diverge — And One Breaks Out — On A Shocking Eczema Development

Technology Nurix, Sanofi Diverge — And One Breaks Out — On A Shocking Eczema Development Licensing Shares of Nurix Therapeutics (NRIX) crashed Wednesday after S...

Nurix, Sanofi Diverge — And One Breaks Out — On A Shocking Eczema Development

Analyst ratings

50%

of 10 ratings
Buy
50%
Hold
50%
Sell
0%

More SNY News

Zacks 2d
RXRX Q3 Earnings Call Highlights Clinical Progress and Cash Runway

Recursion Pharmaceuticals, Inc. (RXRX Quick QuoteRXRX - Free Report) emphasized clinical progress, disciplined spending and an extended cash runway on its...

RXRX Q3 Earnings Call Highlights Clinical Progress and Cash Runway
Investing.com 3d
Sanofi discontinues Nurix drug trial, terminates program - Investing.com

...

Sanofi discontinues Nurix drug trial, terminates program - Investing.com

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.